Infectious Diseases in Obstetrics and Gynecology

Infectious Diseases in Obstetrics and Gynecology / 2007 / Article

Research Article | Open Access

Volume 2007 |Article ID 097424 |

Lauren B. Angotti, Lara C. Lambert, David E. Soper, "Vaginitis: Making Sense of Over-the-Counter Treatment Options", Infectious Diseases in Obstetrics and Gynecology, vol. 2007, Article ID 097424, 4 pages, 2007.

Vaginitis: Making Sense of Over-the-Counter Treatment Options

Received11 Apr 2007
Accepted22 May 2007
Published07 Aug 2007


Background. The FDA approved over-the-counter (OTC) use of vaginal antifungals in 1990. Subsequently, a plethora of OTC products have become available to women on drugstore shelves. Objectives. The purpose of this study was to determine the availability of OTC products marketed for the treatment of vaginitis and to determine if their efficacy had been confirmed by published prospective randomized control trials (RCTs). Materials and methods. The authors chose four retail locations frequented by women seeking vaginitis treatment. All products deemed a viable treatment option were purchased. Results. All intravaginal imidazoles purchased, regardless of treatment duration or active ingredient, were found to be of proven efficacy. We were unable to find an RCT confirming the effectiveness of vaginal anti-itch creams and homeopathic treatments for vaginitis. Conclusion. 45% of products available to women in the feminine hygiene section of the stores surveyed could not be confirmed to be effective for treating infectious vaginitis.


  1. C. Wilson, “Recurrent vulvovaginitis candidiasis: an overview of traditional and alternative therapies,” Advance for Nurse Practitioners, vol. 13, no. 5, pp. 24–29, 2005. View at: Google Scholar
  2. B. Fidler, “Over-the-counter management of vaginal yeast infections,” Drug Store News, pp. 23–27, 2006. View at: Google Scholar
  3. I. Stehlin, “Homeopathy: real medicine or empty promises?,” FDA Consumer, vol. 30, no. 10, pp. 15–19, 1996. View at: Google Scholar
  4. J. P. Borneman and R. I. Field, “Regulation of homeopathic drug products,” American Journal of Health-System Pharmacy, vol. 63, no. 1, pp. 86–91, 2006. View at: Publisher Site | Google Scholar
  5. J. D. Sobel, “Vaginitis,” The New England Journal of Medicine, vol. 337, no. 26, pp. 1896–1903, 1997. View at: Publisher Site | Google Scholar
  6. D. Spence, “Candidiasis (vulvovaginal),” Clinical Evidence, no. 14, pp. 2200–2215, 2005. View at: Google Scholar
  8. NCCAM Questions and Answers about homeopathy.
  9. D. G. Ferris, P. Nyirjesy, J. D. Sobel, D. E. Soper, A. Pavletic, and M. S. Litaker, “Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis,” Obstetrics and Gynecology, vol. 99, no. 3, pp. 419–425, 2002. View at: Publisher Site | Google Scholar
  10. S. Sihvo, R. Ahonenc, H. Mikanderc, and E. Hemminkia, “Self-medication with vaginal anti-fungal drugs: physician's experiences and women's utilization patterns,” Family Practice, vol. 17, no. 2, pp. 145–149, 2000. View at: Publisher Site | Google Scholar
  11. B. A. Liang, “Diagnosis and treatment of infectious vaginitis,” Hospital Physician, vol. 35, no. 10, pp. 46–58, 1999. View at: Google Scholar

Copyright © 2007 Lauren B. Angotti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.